CDXC- $5 area We would suggest initial expected entry ranges from 4.60 to 5.40 area working your way in if possible.  275mm Market cap 50 Million Cash 57mm shares outstanding About ChromaDex: ChromaDex Corp. is an integrated, global nutraceutical company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research...

SSC- Seven Stars Cloud Group $4.29 Maximum Entry 4.75, adding to $3.90 possible 12 month target $10 18 month target $19 possible 52 week high $7 62mm Shares O/S 50% controlled by Insiders/Chairman/CEO 250 Million Market Cap 300 Million Revenues expected for current Fiscal Year Trades at less...

MARK- $9.06 close of 12/18/17-  Remark Holdings Company Website  About Remark Holdings, Inc. Remark Holdings, Inc. (NASDAQ: MARK) primarily focuses on the development and deployment of artificial-intelligence-based solutions for businesses and software developers in many industries.  Additionally, the company owns and operates digital media properties that deliver relevant, dynamic content.  These...

OSTK hit $68 today Recently we said a rally to  61-71 is likely and now with the stock at $68 up from $44-$46 entry, we are taking 1/3 of our shares off the table here to book 50-54% gains. We will buy them back on a big ...

JT- Jianpu Technology  $6.35 area Max buy is 6.50. Many  TPS Members are already long from SRP position, so just hold  if so unless you want more size.- Dave  Recent IPO in November: 22,500,000 shares @ $8.00, below the $8.50 - $10.50 range. Underwriters: Goldman Sachs (Asia)...

Canopy Growth- near $11.50 US Market Cap 1.95 Billion US Website Canopy Growth is at the Tipping Point of investor recognition as the leading Canadian producer of Medical and soon likely Recreational Marijuana.  We have been following this company for a few months or so and in fact...

CLLS- Cellectis $32.50 Investors Website Shares Outstanding: 36 million Cash 200 Million Market Cap 1.15 Billion 80% Ownership of CLXT, currently valued at 650 Million, 80% of which is 520 Million value to CLLS on paper Gene Edited Off-the-shelf Immunotherapies: A Future-defining Shift in Simplicity, Availability, and Cost-effectiveness We first wrote about CLLS back in...

indian xxnx horny desi indian cheating slime wife show boobs in webcam.